[{"Assets_0_FY_USD":430604000.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":67074000.0,"NetIncomeLoss_4_FY_USD":15494000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":11677000.0,"StockholdersEquity_0_FY_USD":197263000.0,"EarningsPerShareBasic_4_FY_USD":1.31,"EarningsPerShareBasic_1_FY_USD":0.46,"Ticker":"ANIP","CIK":"1023024","name":"ANI PHARMACEUTICALS INC","OfficialName":"ANI Pharmaceuticals Inc.","form":"10-K","period":"20181231","fy":"2018.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"569805985.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20190227"}]